Pharmaceutical Industry

Page 45 of 100

Johnson & Johnson CEO Says Fix the Drug Pricing Process, But Not Too Much
Leadership

Johnson & Johnson CEO Says Fix the Drug Pricing Process, But Not Too Much

By
December 4, 2018
pills

Check Your Blood Pressure: These Hypertension Drugs Have Recently Been Recalled

By
December 4, 2018
Novartis CEO Has One New Breakthrough Drug in the Medicine Cabinet: But It Could Be Costly
Leadership

Novartis CEO Has One New Breakthrough Drug in the Medicine Cabinet: But It Could Be Costly

By
November 30, 2018
Pills in prescription bottle

FDA Warns Sixth Valsartan Blood Pressure Drug Recalled for Contamination

By
November 30, 2018
Prescription bottles.

Most Americans Don’t Trust the Government to Lower Prescription Drug Costs

By
November 21, 2018
Morozov Children's City Hospital in Moscow
Health

Boston Scientific Offers $4.2 Billion for British Medical Technology Specialist BTG

By
November 20, 2018
US-POLITICS-TRUMP

Months After Trump Scolded Pfizer About Raising Drug Prices, It’s Raising Prices on 41 Drugs, Report Says

By
November 16, 2018
Prescription pills in a yellow bottle over a wooden table

FDA Recalls Yet Another Blood Pressure Medication, Losartan, Due to Cancer Concerns

By
November 13, 2018
fish oil Amarin Vascepa
Health

Explaining Amarin’s Fishy Stock Slide

By
November 12, 2018
Doctor Measuring arterial blood pressure woman patient on right arm Health care in hospita

Another Popular Blood Pressure Drug Has Been Recalled by the FDA Over Potential Cancer Risk

By
November 1, 2018
US-RETAIL-STORE
Retail

CVS Is Testing Out Prime-Like Memberships as Amazon Jumps Into Prescription Drugs

By
October 31, 2018
Veracruz Rebounds After The Mexican Military Secures The City
Health

A Health Insurer’s Latest Plan to Cut Drug Costs? Pay Patients to Visit Mexico

By
October 31, 2018
Genentech new flu drug
Health

The FDA Approved the First Big New Flu Drug in Almost 20 Years—And Is Approaching a Drug Approval Record

By
October 24, 2018
Healthcare Fortune Future 50
Health

These Are the Health Care Companies Poised for Explosive Growth

By
October 18, 2018
SWITZERLAND-PHARMACEUTICAL-EARNINGS-HEALTH-NOVARTIS
Health

Novartis Is Paying $2.1 Billion for Endocyte, a Company That’s Developing a New Prostate Cancer Treatment

By
October 18, 2018

Most Popular